Biopharma insights that others miss
Sleuth helps biopharma teams get to conviction faster, turning complex strategic questions into clear, evidence-backed answers in hours instead of months.
Non-obvious insights from complex data
The most consequential strategic decisions hinge on insights that sit across thousands of data points — connections that span biology, clinical evidence, competitive dynamics, and deal history. Sleuth surfaces the second- and third-order patterns across these domains, revealing undervalued assets, overlooked mechanisms, and competitive gaps.
Question to conviction in hours, not months
When a board question lands or a deal window opens, weeks of traditional analysis isn't an option. Sleuth delivers executive-ready analysis with the urgency the question demands, and keeps it current as the market moves, leadership pushes back, or new questions emerge. Living analyses, not static deliverables.
Analysis that reflects your thinking
Most strategic analysis arrives in a generic framework your team has to translate — remapping someone else's structure to your therapeutic priorities, your science, your competitive set, and your way of evaluating opportunities. Sleuth starts from your context, so the output reflects how your team actually thinks about the problem.
Latest from Sleuth Intelligence
Original biopharma analysis from the Sleuth team, applying our platform to the questions shaping the industry. Competitive landscapes, deal flow, portfolio strategy, and more.
Where fragmented data becomes connected knowledge
Sleuth is built on a proprietary knowledge graph that continuously acquires, structures, and links information from across the biopharma ecosystem, so what you get is connected knowledge, not another data dump without context. Purpose-built for biopharma, not a general-purpose model guessing at science.
A billion relationships, already mapped.
Drugs, trials, targets, patents, companies, and deals — connected and deduplicated across sources.
Comprehensive coverage, continuously updated.
Hundreds of sources refreshed daily. Including sell-side research, China pipelines, and early-stage signals most platforms miss.
Every insight traces to source.
Follow any conclusion back to the underlying document, paragraph, or data point.
Your data stays yours.
Proprietary queries and uploads are never shared or used to train models.
What teams are saying
"What makes Sleuth stand out is its rare combination of speed and credibility. The output is factual, well-structured, and decision-useful, making it a valuable input into internal discussions and executive conversations. It has raised our expectations for how quickly broad complexity can be translated into a clearer, more refined strategic narrative."
“All the strategy that used to be proprietary to pharma — the ‘game within the game’ that actually drives indication decisions — Sleuth made that accessible to a nine-person biotech. I think it's the most disruptive, amazing thing for small organizations like us. A massive, massive unlock.”
%201.svg)